Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The Silence Speaks, but We Do Not Listen: Synonymous c.1824C>T Gene Variant in the Last Exon of the Prothrombin Gene as a New Prothrombotic Risk Factor.

Pruner I, Farm M, Tomic B, Gvozdenov M, Kovac M, Miljic P, Soutari NMH, Antovic A, Radojkovic D, Antovic J, Djordjevic V.

Clin Chem. 2020 Feb 1;66(2):379-389. doi: 10.1093/clinchem/hvz015.

PMID:
32040579
2.

The antiphospholipid syndrome - often overlooked cause of vascular occlusions?

Svenungsson E, Antovic A.

J Intern Med. 2020 Jan 19. doi: 10.1111/joim.13022. [Epub ahead of print] Review.

PMID:
31957081
3.

Pancreatic Polypeptide-Secreting Tumour of the Proximal Pancreas (PPoma)-Ultra Rare Pancreatic Tumour: Clinically Malign, Histologically Benign.

Ilić I, Katić V, Randjelović P, Stojanović N, Antovic A, Ilić R.

Medicina (Kaunas). 2019 Aug 23;55(9). pii: E523. doi: 10.3390/medicina55090523.

4.

Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Antovic A, Mobarrez F, Manojlovic M, Soutari N, De Porta Baggemar V, Nordin A, Bruchfeld A, Vojinovic J, Gunnarsson I.

J Rheumatol. 2019 Aug 1. pii: jrheum.181347. doi: 10.3899/jrheum.181347. [Epub ahead of print]

PMID:
31371653
5.

Assessment of hemostatic disturbances in women with established rheumatoid arthritis.

Vranic A, Pruner I, Veselinovic M, Soutari N, Petkovic A, Jakovljevic V, Antovic A.

Clin Rheumatol. 2019 Nov;38(11):3005-3014. doi: 10.1007/s10067-019-04629-8. Epub 2019 Jun 17.

PMID:
31209709
6.

Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile.

Högdén A, Antovic A, Berg E, Bremme K, Chaireti R.

Lupus. 2019 Jun;28(7):868-877. doi: 10.1177/0961203319852155. Epub 2019 May 27.

PMID:
31132916
7.

Obstetric antiphospholipid syndrome.

Antovic A, Sennström M, Bremme K, Svenungsson E.

Lupus Sci Med. 2018 Sep 25;5(1):e000197. doi: 10.1136/lupus-2016-000197. eCollection 2018. Review.

8.

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset.

Antovic A, Notarnicola A, Svensson J, Lundberg IE, Holmqvist M.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1849-1855. doi: 10.1002/acr.23560.

9.

QSPR in forensic analysis - The prediction of retention time of pesticide residues based on the Monte Carlo method.

Zdravković M, Antović A, Veselinović JB, Sokolović D, Veselinović AM.

Talanta. 2018 Feb 1;178:656-662. doi: 10.1016/j.talanta.2017.09.064. Epub 2017 Sep 23.

PMID:
29136877
10.

Immunohistochemical distribution of Ki67 in epidermis of thick glabrous skin of human digits.

Petrovic A, Petrovic V, Milojkovic B, Nikolic I, Jovanovic D, Antovic A, Milic M.

Arch Dermatol Res. 2018 Jan;310(1):85-93. doi: 10.1007/s00403-017-1793-5. Epub 2017 Nov 8.

PMID:
29119273
11.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A.

Thromb Res. 2017 Oct;158:168-173. doi: 10.1016/j.thromres.2017.06.028. Epub 2017 Jun 24.

PMID:
28669410
12.

Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.

Antovic A, Norberg EM, Berndtsson M, Rasmuson A, Malmström RE, Skeppholm M, Antovic J.

Thromb Haemost. 2017 Aug 30;117(9):1700-1704. doi: 10.1160/TH17-03-0204. Epub 2017 Jun 22.

PMID:
28640321
13.

The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.

Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, Jörneskog G, Wallen H.

Clin Endocrinol (Oxf). 2016 May;84(5):729-35. doi: 10.1111/cen.12872. Epub 2015 Sep 22.

PMID:
26252432
14.

Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis.

Vucelic D, Jesic R, Jovicic S, Zivotic M, Grubor N, Trajkovic G, Canic I, Elezovic I, Antovic A.

Thromb Res. 2015 Jun;135(6):1124-30. doi: 10.1016/j.thromres.2015.04.003. Epub 2015 Apr 11.

PMID:
25900310
15.

Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.

Tehrani S, Jörneskog G, Ågren A, Lins PE, Wallén H, Antovic A.

Thromb Haemost. 2015 Feb;113(2):312-8. doi: 10.1160/TH14-05-0404. Epub 2014 Oct 16.

PMID:
25318636
16.

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

Vikerfors A, Svenungsson E, Ågren A, Mobarrez F, Bremme K, Holmström M, Eelde A, Bruzelius M, Elgue G, Wallén H, Antovic A.

Thromb Res. 2014 May;133(5):936-44. doi: 10.1016/j.thromres.2014.02.023. Epub 2014 Feb 28.

PMID:
24630645
17.

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.

Antovic A, Mikovic D, Elezovic I, Zabczyk M, Hutenby K, Antovic JP.

Thromb Haemost. 2014 Apr 1;111(4):656-61. doi: 10.1160/TH13-06-0479. Epub 2013 Nov 21.

PMID:
24258360
18.

Unusual suicide with a chainsaw.

Stojanović I, Milić M, Antović A, Todorović S, Jovanović I.

Forensic Sci Int. 2013 May 10;228(1-3):e58-61. doi: 10.1016/j.forsciint.2013.02.011. Epub 2013 Feb 26.

PMID:
23452874
19.

Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?

Mobarrez F, Mikovic D, Antovic A, Antovic JP.

J Thromb Haemost. 2013 Apr;11(4):697-703. doi: 10.1111/jth.12103.

20.

Human basilar artery abnormalities in the prenatal and postnatal period.

Vasović L, Trandafilović M, Jovanović I, Ugrenović S, Antović A, Karadžić R, Stojanović I.

World Neurosurg. 2013 Mar-Apr;79(3-4):593.e15-23. doi: 10.1016/j.wneu.2012.06.033. Epub 2012 Jun 21.

PMID:
22728664
21.

Studies of microparticles in patients with the antiphospholipid syndrome (APS).

Vikerfors A, Mobarrez F, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Antovic A, Wallén H, Svenungsson E.

Lupus. 2012 Jun;21(7):802-5. doi: 10.1177/0961203312437809.

PMID:
22635239
22.

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.

Antovic JP, Mikovic D, Elezovic I, Holmström M, Wilkens M, Elfvinge P, Mahmoud Hourani Soutari N, Antovic A.

Thromb Haemost. 2012 Jul;108(1):21-31. doi: 10.1160/TH11-11-0811. Epub 2012 Apr 26.

PMID:
22534727
23.

Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis.

Westerlund E, Henriksson P, Wallén H, Hovatta O, Wallberg KR, Antovic A.

Thromb Res. 2012 Oct;130(4):649-53. doi: 10.1016/j.thromres.2011.11.024. Epub 2011 Dec 7.

PMID:
22154245
24.

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Tehrani S, Antovic A, Mobarrez F, Mageed K, Lins PE, Adamson U, Wallén HN, Jörneskog G.

Diabetes Care. 2012 Feb;35(2):404-8. doi: 10.2337/dc11-1302. Epub 2011 Dec 6.

25.

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.

Mikovic D, Woodhams BJ, Holmström M, Elezovic I, Antovic A, Mobarrez F, Elfvinge P, Antovic JP.

Int J Lab Hematol. 2012 Feb;34(1):35-40. doi: 10.1111/j.1751-553X.2011.01349.x. Epub 2011 Jun 27.

PMID:
21707936
26.

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Mobarrez F, He S, Bröijersen A, Wiklund B, Antovic A, Antovic J, Egberg N, Jörneskog G, Wallén H.

Thromb Haemost. 2011 Aug;106(2):344-52. doi: 10.1160/TH10-12-0810. Epub 2011 May 26.

PMID:
21614411
27.

Changes in von Willebrand factor and ADAMTS13 during IVF.

Westerlund E, Antovic A, Hovatta O, Eberg KP, Blombäck M, Wallén H, Henriksson P.

Blood Coagul Fibrinolysis. 2011 Mar;22(2):127-31. doi: 10.1097/MBC.0b013e32834363ea.

PMID:
21192251
28.

The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.

Antovic A.

Semin Thromb Hemost. 2010 Oct;36(7):772-9. doi: 10.1055/s-0030-1265294. Epub 2010 Oct 26. Review.

PMID:
20978998
29.

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallén NH, Jörneskog G.

Thromb Res. 2010 Sep;126(3):e225-31. doi: 10.1016/j.thromres.2010.05.023. Epub 2010 Jul 15.

PMID:
20637495
30.

An excess vessel in the posterior part of the human cerebral arterial circle (CAC): a case series.

Vasović L, Trandafilović M, Jovanović I, Antović A, Stojanović J, Zdravković M, Milić M.

BMC Neurol. 2010 Jun 23;10:53. doi: 10.1186/1471-2377-10-53.

31.

Ultrastructural changes in the liver of intravenous heroin addicts.

Ilic G, Karadzic R, Kostic-Banovic L, Stojanovic J, Antovic A.

Bosn J Basic Med Sci. 2010 Feb;10(1):38-43.

33.

Comparison of two laboratory assays for the investigation of fibrin gel porosity.

Antovic A, Jörneskog G, Wallen NH.

Thromb Haemost. 2007 Dec;98(6):1386-8. No abstract available.

PMID:
18064345
34.

Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.

Rooth E, Wallen H, Antovic A, von Arbin M, Kaponides G, Wahlgren N, Blombäck M, Antovic J.

Blood Coagul Fibrinolysis. 2007 Jun;18(4):365-70.

PMID:
17473579
35.

Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia.

Anzej S, Bozic M, Antovic A, Peternel P, Gaspersic N, Rot U, Tratar G, Stegnar M.

Thromb Res. 2007;120(1):39-46. Epub 2006 Oct 10.

PMID:
17034835
36.

Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma.

Antovic A, Blombäck M, Sten-Linder M, Petrini P, Holmström M, He S.

Blood Coagul Fibrinolysis. 2005 Nov;16(8):585-96.

PMID:
16269934
37.

Specifics of Helicobacter pylori infection/NSAID effects in the elderly.

Davidovic M, Svorcan P, Milanovic P, Antovic A, Milosevic D.

Rom J Gastroenterol. 2005 Sep;14(3):253-8. Review.

38.

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S.

Thromb Res. 2005;116(6):509-17.

PMID:
16181986
39.

Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.

Vedin J, Antovic A, Ericsson A, Vaage J.

Ann Thorac Surg. 2005 Aug;80(2):586-93.

PMID:
16039210
40.

Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials.

He S, Cao H, Antovic A, Blombäck M.

Blood Coagul Fibrinolysis. 2005 Jan;16(1):61-7.

PMID:
15650548
41.

Overall hemostatic potential (OHP) assay-a possible tool for determination of prothrombotic pattern in FXII deficiency.

Antovic JP, Antovic A, Sten-Linder M, Wramsby M, Blombäck M.

J Thromb Haemost. 2004 Nov;2(11):2058-60. No abstract available.

42.

Gastropathy of old age: Helicobacter pylori infection or NSAID use.

Davidovic M, Svorcan P, Milanovic P, Antovic A, Milosevic DP.

MedGenMed. 2004 Mar 30;6(1):32. No abstract available.

43.

Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance.

Antovic A, Blombäck M, Bremme K, Van Rooijen M, He S.

J Thromb Haemost. 2003 Dec;1(12):2531-5.

45.

Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.

Antovic JP, Yngen M, Ostenson CG, Antovic A, Wallen HN, Jorneskög G, Blombäck M.

Blood Coagul Fibrinolysis. 2003 Sep;14(6):551-6.

PMID:
12960608
47.
48.

Supplemental Content

Loading ...
Support Center